CIK 0001850906
OMIC Singular Genomics Systems, Inc.
Insider trading from SEC Form 4. Last filing Feb 25, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at Singular Genomics Systems, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Andrew Spaventa Chief Executive Officer sell | $3,629 180 shares | -22% | - | |
| 20Weak | Andrew Spaventa Chief Executive Officer sell | $16k 695 shares | -31% | - |
Transactions
The last 50 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | David L Barker director | DDisposition to issuer Common Stock | -60,000 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Kim P. Kamdar director | DDisposition to issuer Common Stock | -15,000 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Eli N. Glezer Chief Scientific Officer | DDisposition to issuer Common Stock | -155,583 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Marcia Eisenberg director | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,933 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Jyotsna Ghai Chief Operating Officer | DDisposition to issuer Common Stock | -3,283 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | David L Barker director | DDisposition to issuer Common Stockindirect: The Barker/Loring Trust Dated August 27, 2013 | -1,000,000 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Kim P. Kamdar director | DDisposition to issuer Common Stockindirect: By Domain Partners IX, L.P. | -3,763,985 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Eli N. Glezer Chief Scientific Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,666 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Jyotsna Ghai Chief Operating Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -13,333 | $9.20 | $123k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Marcia Eisenberg director | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,850 | $8.84 | $16k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Jyotsna Ghai Chief Operating Officer | DDisposition to issuer Restricted Stock Unitderivative | -3,000 | $20.00 | $60k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Kim P. Kamdar director | DDisposition to issuer Common Stockindirect: By Domain Associates, LLC | -15,000 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | David L Barker director | DDisposition to issuer Stock Option (Right to Buy)derivative | -666 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Eli N. Glezer Chief Scientific Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,999 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Eli N. Glezer Chief Scientific Officer | DDisposition to issuer Restricted Stock Unitderivative | -6,000 | $20.00 | $120k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | David L Barker director | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,541 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Jyotsna Ghai Chief Operating Officer | DDisposition to issuer Restricted Stock Unitderivative | -4,583 | $20.00 | $92k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Kim P. Kamdar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -666 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | David L Barker director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,466 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Eli N. Glezer Chief Scientific Officer | DDisposition to issuer Restricted Stock Unitderivative | -2,250 | $20.00 | $45k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Kim P. Kamdar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,541 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | David L Barker director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,466 | $8.84 | $22k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Kim P. Kamdar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,466 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | Kim P. Kamdar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,466 | $8.84 | $22k | 0 | Feb 25, 2025 |
| Feb 9, 2025 | Jyotsna Ghai Chief Operating Officer | MOption exercise Common Stock | +250 | - | - | 3,283 | Feb 11, 2025 |
| Feb 9, 2025 | Eli N. Glezer Chief Scientific Officer | MOption exercise Common Stock | +500 | - | - | 155,583 | Feb 11, 2025 |
| Feb 9, 2025 | Jyotsna Ghai Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -250 | - | - | 3,000 | Feb 11, 2025 |
| Feb 9, 2025 | Eli N. Glezer Chief Scientific Officer | MOption exercise Restricted Stock Unitsderivative | -500 | - | - | 6,000 | Feb 11, 2025 |
| Jan 2, 2025 | Jyotsna Ghai Chief Operating Officer | MOption exercise Common Stock | +417 | - | - | 3,033 | Jan 6, 2025 |
| Jan 2, 2025 | Jyotsna Ghai Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -417 | - | - | 4,583 | Jan 6, 2025 |
| Dec 15, 2024 | Eli N. Glezer Chief Scientific Officer | MOption exercise Common Stock | +250 | - | - | 155,083 | Dec 17, 2024 |
| Dec 15, 2024 | Dalen Meeter Chief Financial Officer | MOption exercise Common Stock | +209 | - | - | 9,002 | Dec 17, 2024 |
| Dec 15, 2024 | Andrew Spaventa Chief Executive Officer | MOption exercise Common Stock | +486 | - | - | 811 | Dec 17, 2024 |
| Dec 16, 2024 | Andrew Spaventa Chief Executive Officer | SOpen-market sale Common Stock | -180 | $20.16 | $3,629 | 631 | Dec 17, 2024 |
| Dec 15, 2024 | Eli N. Glezer Chief Scientific Officer | MOption exercise Restricted Stock Unitsderivative | -250 | - | - | 2,250 | Dec 17, 2024 |
| Dec 15, 2024 | Dalen Meeter Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -209 | - | - | 1,874 | Dec 17, 2024 |
| Dec 16, 2024 | Andrew Spaventa Chief Executive Officer | GGift Common Stock | -306 | $0.00 | $0 | 325 | Dec 17, 2024 |
| Dec 16, 2024 | Andrew Spaventa Chief Executive Officer | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +306 | $0.00 | $0 | 141,793 | Dec 17, 2024 |
| Dec 15, 2024 | Andrew Spaventa Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -486 | $0.00 | $0 | 4,374 | Dec 17, 2024 |
| Nov 12, 2024 | Andrew Spaventa Chief Executive Officer | MOption exercise Common Stock | +1,907 | - | - | 2,232 | Nov 13, 2024 |
| Nov 9, 2024 | Jyotsna Ghai Chief Operating Officer | MOption exercise Common Stock | +250 | - | - | 2,516 | Nov 13, 2024 |
| Nov 9, 2024 | Eli N. Glezer Chief Scientific Officer | MOption exercise Common Stock | +500 | - | - | 154,833 | Nov 13, 2024 |
| Nov 9, 2024 | Dalen Meeter Chief Financial Officer | MOption exercise Common Stock | +500 | - | - | 8,693 | Nov 13, 2024 |
| Nov 12, 2024 | Andrew Spaventa Chief Executive Officer | SOpen-market sale Common Stock | -695 | $22.55 | $16k | 1,537 | Nov 13, 2024 |
| Nov 9, 2024 | Jyotsna Ghai Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -250 | - | - | 3,250 | Nov 13, 2024 |
| Nov 9, 2024 | Eli N. Glezer Chief Scientific Officer | MOption exercise Restricted Stock Unitsderivative | -500 | - | - | 6,500 | Nov 13, 2024 |
| Nov 9, 2024 | Dalen Meeter Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -500 | - | - | 6,500 | Nov 13, 2024 |
| Nov 12, 2024 | Andrew Spaventa Chief Executive Officer | GGift Common Stock | -1,212 | $0.00 | $0 | 325 | Nov 13, 2024 |
| Nov 12, 2024 | Andrew Spaventa Chief Executive Officer | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +1,212 | $0.00 | $0 | 141,487 | Nov 13, 2024 |
| Nov 12, 2024 | Andrew Spaventa Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -1,907 | $0.00 | $0 | 24,780 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- David L Barkerdirector
- Marcia Eisenbergdirector
- Jyotsna GhaiChief Operating Officer
- Eli N. GlezerChief Scientific Officer
- Kim P. Kamdardirector
- Dalen MeeterChief Financial Officer
- Andrew SpaventaChief Executive Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.